250 related articles for article (PubMed ID: 29101597)
21. Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial.
Duraes M; Garbay M; Ferrer C; Duflos C; Rathat G
BMJ Open; 2023 Dec; 13(12):e071756. PubMed ID: 38070928
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.
Khan QJ; Kimler BF; Reddy PS; Sharma P; Klemp JR; Nydegger JL; Yeh HW; Fabian CJ
Breast Cancer Res Treat; 2017 Nov; 166(2):491-500. PubMed ID: 28770449
[TBL] [Abstract][Full Text] [Related]
23. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
[TBL] [Abstract][Full Text] [Related]
24. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D
Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132
[TBL] [Abstract][Full Text] [Related]
25. Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.
Olufade T; Gallicchio L; MacDonald R; Helzlsouer KJ
Support Care Cancer; 2015 Feb; 23(2):447-55. PubMed ID: 25128067
[TBL] [Abstract][Full Text] [Related]
26. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
Chim K; Xie SX; Stricker CT; Li QS; Gross R; Farrar JT; DeMichele A; Mao JJ
BMC Cancer; 2013 Sep; 13():401. PubMed ID: 24004677
[TBL] [Abstract][Full Text] [Related]
27. Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
Borreani C; Alfieri S; Infante G; Miceli R; Mariani P; Bosisio M; Vernieri C; Bianchi GV; Capri G
Oncology; 2021; 99(2):84-95. PubMed ID: 32992318
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms.
Helzlsouer KJ; Gallicchio L; MacDonald R; Wood B; Rushovich E
Breast Cancer Res Treat; 2012 Jan; 131(1):277-85. PubMed ID: 21904883
[TBL] [Abstract][Full Text] [Related]
29. Chinese Medicine Yishen Jiangu Granules () on Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
Zhang X; Peng N; Yu MW; Zhang GL; Sun X; Yang GW; Li C; Yang L; Wang XM
Chin J Integr Med; 2018 Nov; 24(11):867-872. PubMed ID: 30062634
[TBL] [Abstract][Full Text] [Related]
30. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.
Shanmugam VK; McCloskey J; Elston B; Allison SJ; Eng-Wong J
Breast Cancer Res Treat; 2012 Jan; 131(2):699-708. PubMed ID: 22076476
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 Fatty Acid Supplementation Improves Endothelial Function in Primary Antiphospholipid Syndrome: A Small-Scale Randomized Double-Blind Placebo-Controlled Trial.
Felau SM; Sales LP; Solis MY; Hayashi AP; Roschel H; Sá-Pinto AL; Andrade DCO; Katayama KY; Irigoyen MC; Consolim-Colombo F; Bonfa E; Gualano B; Benatti FB
Front Immunol; 2018; 9():336. PubMed ID: 29552010
[TBL] [Abstract][Full Text] [Related]
32. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
Galantino ML; Desai K; Greene L; Demichele A; Stricker CT; Mao JJ
Integr Cancer Ther; 2012 Dec; 11(4):313-20. PubMed ID: 21733988
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
[TBL] [Abstract][Full Text] [Related]
34. Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
Shenouda M; Copley R; Pacioles T; Lebowicz Y; Jamil M; Akpanudo S; Tirona MT
Clin Breast Cancer; 2022 Jan; 22(1):e30-e36. PubMed ID: 34275765
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.
Wang T; Huang YY; Liu XL; Molassiotis A; Yao LQ; Zheng SL; Tan JB; Huang HQ
Support Care Cancer; 2022 Nov; 30(11):9279-9288. PubMed ID: 36065027
[TBL] [Abstract][Full Text] [Related]
36. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
Lintermans A; Van Asten K; Wildiers H; Laenen A; Paridaens R; Weltens C; Verhaeghe J; Vanderschueren D; Smeets A; Van Limbergen E; Leunen K; Christiaens MR; Neven P
Breast Cancer Res Treat; 2014 Jul; 146(1):109-16. PubMed ID: 24816806
[TBL] [Abstract][Full Text] [Related]
37. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
Bhave MA; Speth KA; Kidwell KM; Lyden A; Alsamarraie C; Murphy SL; Henry NL
Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
[TBL] [Abstract][Full Text] [Related]
38. Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial.
Peng N; Zhang Y; Ma C; Yu MW; Yang GW; Fu Q; Xu WR; Wang XM
Trials; 2014 May; 15():171. PubMed ID: 24885324
[TBL] [Abstract][Full Text] [Related]
39. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
Henry NL; Unger JM; Till C; Crew KD; Fisch MJ; Hershman DL
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34901744
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
